Selected research
Industry Research
Medical Nuclide Products Industry Research Report 2026
Market perspective
The global Medical Nuclide Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Medical Nuclide Products market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Medical Nuclide Products market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Medical Nuclide Products market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Medical Nuclide Products include China Isotope & Radiation, Dongcheng Pharma, Eli Lilly, Junan Pharmaceutical, Bayer, Siemens, Q BioMed, Progenics Pharmaceuticals and Polatom, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Medical Nuclide Products market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Medical Nuclide Products.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Nuclide Products Market by Company
China Isotope & Radiation
Dongcheng Pharma
Eli Lilly
Junan Pharmaceutical
Bayer
Siemens
Q BioMed
Progenics Pharmaceuticals
Polatom
NTP Radioisotopes
NRG
Novartis International AG
Nordion
Mundipharma
Monrol
Lantheus Medical Imaging, Inc.
Jubilant Life Sciences
International Isotopes
GE Healthcare
Eckert & Ziegler Strahlen
Curium Pharma
Cardinal Health
Bracco Imaging
Aurobindo Pharma
ANSTO
Acrotech Biopharma.
Medical Nuclide Products Segment by Type
Radiopharmaceuticals
Radioactive Sources
Medical Diagnostic Nuclides
Others
Medical Nuclide Products Segment by Application
Hematological Diseases
Cardiovascular Diseases
Bone and Joint Diseases
Cancer
Others
Medical Nuclide Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Nuclide Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Nuclide Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Nuclide Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Nuclide Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Medical Nuclide Products Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Medical Nuclide Products Revenue Market Share by Type (2021-2026)
Table 7. Global Medical Nuclide Products Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Medical Nuclide Products Revenue Market Share by Type (2027-2032)
Table 9. Global Medical Nuclide Products Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Medical Nuclide Products Revenue Market Share by Application (2021-2026)
Table 11. Global Medical Nuclide Products Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Medical Nuclide Products Revenue Market Share by Application (2027-2032)
Table 13. Global Medical Nuclide Products Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Medical Nuclide Products Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Medical Nuclide Products Market Share by Region (2021-2026)
Table 16. Global Medical Nuclide Products Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Medical Nuclide Products Market Share by Region (2027-2032)
Table 18. Medical Nuclide Products Industry Trends
Table 19. Medical Nuclide Products Industry Drivers
Table 20. Medical Nuclide Products Industry Opportunities and Challenges
Table 21. Medical Nuclide Products Market Restraints
Table 22. Global Top Medical Nuclide Products Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Medical Nuclide Products Revenue Market Share by Players (2021-2026)
Table 24. Global Medical Nuclide Products Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Medical Nuclide Products, Headquarters and Area Served
Table 26. Global Medical Nuclide Products Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Medical Nuclide Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Medical Nuclide Products Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Medical Nuclide Products Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Medical Nuclide Products Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Medical Nuclide Products Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Medical Nuclide Products Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Medical Nuclide Products Market Size by Country (2027-2032) & (US$ Million)
Table 45. China Isotope & Radiation Company Information
Table 46. China Isotope & Radiation Business Overview
Table 47. China Isotope & Radiation Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 48. China Isotope & Radiation Medical Nuclide Products Product Portfolio
Table 49. China Isotope & Radiation Recent Developments
Table 50. Dongcheng Pharma Company Information
Table 51. Dongcheng Pharma Business Overview
Table 52. Dongcheng Pharma Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 53. Dongcheng Pharma Medical Nuclide Products Product Portfolio
Table 54. Dongcheng Pharma Recent Developments
Table 55. Eli Lilly Company Information
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 58. Eli Lilly Medical Nuclide Products Product Portfolio
Table 59. Eli Lilly Recent Developments
Table 60. Junan Pharmaceutical Company Information
Table 61. Junan Pharmaceutical Business Overview
Table 62. Junan Pharmaceutical Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 63. Junan Pharmaceutical Medical Nuclide Products Product Portfolio
Table 64. Junan Pharmaceutical Recent Developments
Table 65. Bayer Company Information
Table 66. Bayer Business Overview
Table 67. Bayer Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 68. Bayer Medical Nuclide Products Product Portfolio
Table 69. Bayer Recent Developments
Table 70. Siemens Company Information
Table 71. Siemens Business Overview
Table 72. Siemens Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 73. Siemens Medical Nuclide Products Product Portfolio
Table 74. Siemens Recent Developments
Table 75. Q BioMed Company Information
Table 76. Q BioMed Business Overview
Table 77. Q BioMed Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 78. Q BioMed Medical Nuclide Products Product Portfolio
Table 79. Q BioMed Recent Developments
Table 80. Progenics Pharmaceuticals Company Information
Table 81. Progenics Pharmaceuticals Business Overview
Table 82. Progenics Pharmaceuticals Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 83. Progenics Pharmaceuticals Medical Nuclide Products Product Portfolio
Table 84. Progenics Pharmaceuticals Recent Developments
Table 85. Polatom Company Information
Table 86. Polatom Business Overview
Table 87. Polatom Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 88. Polatom Medical Nuclide Products Product Portfolio
Table 89. Polatom Recent Developments
Table 90. NTP Radioisotopes Company Information
Table 91. NTP Radioisotopes Business Overview
Table 92. NTP Radioisotopes Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 93. NTP Radioisotopes Medical Nuclide Products Product Portfolio
Table 94. NTP Radioisotopes Recent Developments
Table 95. NRG Company Information
Table 96. NRG Business Overview
Table 97. NRG Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 98. NRG Medical Nuclide Products Product Portfolio
Table 99. NRG Recent Developments
Table 100. Novartis International AG Company Information
Table 101. Novartis International AG Business Overview
Table 102. Novartis International AG Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 103. Novartis International AG Medical Nuclide Products Product Portfolio
Table 104. Novartis International AG Recent Developments
Table 105. Nordion Company Information
Table 106. Nordion Business Overview
Table 107. Nordion Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 108. Nordion Medical Nuclide Products Product Portfolio
Table 109. Nordion Recent Developments
Table 110. Mundipharma Company Information
Table 111. Mundipharma Business Overview
Table 112. Mundipharma Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 113. Mundipharma Medical Nuclide Products Product Portfolio
Table 114. Mundipharma Recent Developments
Table 115. Monrol Company Information
Table 116. Monrol Business Overview
Table 117. Monrol Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 118. Monrol Medical Nuclide Products Product Portfolio
Table 119. Monrol Recent Developments
Table 120. Lantheus Medical Imaging, Inc. Company Information
Table 121. Lantheus Medical Imaging, Inc. Business Overview
Table 122. Lantheus Medical Imaging, Inc. Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 123. Lantheus Medical Imaging, Inc. Medical Nuclide Products Product Portfolio
Table 124. Lantheus Medical Imaging, Inc. Recent Developments
Table 125. Jubilant Life Sciences Company Information
Table 126. Jubilant Life Sciences Business Overview
Table 127. Jubilant Life Sciences Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 128. Jubilant Life Sciences Medical Nuclide Products Product Portfolio
Table 129. Jubilant Life Sciences Recent Developments
Table 130. International Isotopes Company Information
Table 131. International Isotopes Business Overview
Table 132. International Isotopes Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 133. International Isotopes Medical Nuclide Products Product Portfolio
Table 134. International Isotopes Recent Developments
Table 135. GE Healthcare Company Information
Table 136. GE Healthcare Business Overview
Table 137. GE Healthcare Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 138. GE Healthcare Medical Nuclide Products Product Portfolio
Table 139. GE Healthcare Recent Developments
Table 140. Eckert & Ziegler Strahlen Company Information
Table 141. Eckert & Ziegler Strahlen Business Overview
Table 142. Eckert & Ziegler Strahlen Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 143. Eckert & Ziegler Strahlen Medical Nuclide Products Product Portfolio
Table 144. Eckert & Ziegler Strahlen Recent Developments
Table 145. Curium Pharma Company Information
Table 146. Curium Pharma Business Overview
Table 147. Curium Pharma Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 148. Curium Pharma Medical Nuclide Products Product Portfolio
Table 149. Curium Pharma Recent Developments
Table 150. Cardinal Health Company Information
Table 151. Cardinal Health Business Overview
Table 152. Cardinal Health Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 153. Cardinal Health Medical Nuclide Products Product Portfolio
Table 154. Cardinal Health Recent Developments
Table 155. Bracco Imaging Company Information
Table 156. Bracco Imaging Business Overview
Table 157. Bracco Imaging Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 158. Bracco Imaging Medical Nuclide Products Product Portfolio
Table 159. Bracco Imaging Recent Developments
Table 160. Aurobindo Pharma Company Information
Table 161. Aurobindo Pharma Business Overview
Table 162. Aurobindo Pharma Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 163. Aurobindo Pharma Medical Nuclide Products Product Portfolio
Table 164. Aurobindo Pharma Recent Developments
Table 165. ANSTO Company Information
Table 166. ANSTO Business Overview
Table 167. ANSTO Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 168. ANSTO Medical Nuclide Products Product Portfolio
Table 169. ANSTO Recent Developments
Table 170. Acrotech Biopharma. Company Information
Table 171. Acrotech Biopharma. Business Overview
Table 172. Acrotech Biopharma. Revenue in Medical Nuclide Products Business (2021-2026) & (US$ Million)
Table 173. Acrotech Biopharma. Medical Nuclide Products Product Portfolio
Table 174. Acrotech Biopharma. Recent Developments
Table 175. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Medical Nuclide Products Product Image
Figure 5. Global Medical Nuclide Products Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Medical Nuclide Products Market Share by Type: 2025 VS 2032
Figure 7. Radiopharmaceuticals Product
Figure 8. Radioactive Sources Product
Figure 9. Medical Diagnostic Nuclides Product
Figure 10. Others Product
Figure 11. Global Medical Nuclide Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Medical Nuclide Products Market Share by Application: 2025 VS 2032
Figure 13. Hematological Diseases Product
Figure 14. Cardiovascular Diseases Product
Figure 15. Bone and Joint Diseases Product
Figure 16. Cancer Product
Figure 17. Others Product
Figure 18. Global Medical Nuclide Products Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 19. Global Medical Nuclide Products Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 20. Global Medical Nuclide Products Market Share by Region: 2025 VS 2032
Figure 21. Global Medical Nuclide Products Market Share by Players in 2025
Figure 22. Global Medical Nuclide Products Manufacturers Established Date
Figure 23. Global Top 5 and 10 Medical Nuclide Products Players Market Share by Revenue in 2025
Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 25. North America Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. North America Medical Nuclide Products Market Share by Country (2021-2032)
Figure 27. United States Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Canada Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Mexico Medical Nuclide Products Market Share by Country (2021-2032)
Figure 30. Europe Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Europe Medical Nuclide Products Market Share by Country (2021-2032)
Figure 32. Germany Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. France Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. U.K. Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Italy Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Spain Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Russia Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Netherlands Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Nordic Countries Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Asia-Pacific Medical Nuclide Products Market Share by Country (2021-2032)
Figure 42. China Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. Japan Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. South Korea Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. India Medical Nuclide Products Market Share by Country (2021-2032)
Figure 47. Australia Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. China Taiwan Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. South America Medical Nuclide Products Market Share by Country (2021-2032)
Figure 52. Brazil Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Argentina Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Chile Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Colombia Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Peru Medical Nuclide Products Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 57. China Isotope & Radiation Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 58. Dongcheng Pharma Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 59. Eli Lilly Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 60. Junan Pharmaceutical Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 61. Bayer Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 62. Siemens Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 63. Q BioMed Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 64. Progenics Pharmaceuticals Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 65. Polatom Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 66. NTP Radioisotopes Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 67. NRG Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 68. Novartis International AG Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 69. Nordion Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 70. Mundipharma Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 71. Monrol Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 72. Lantheus Medical Imaging, Inc. Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 73. Jubilant Life Sciences Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 74. International Isotopes Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 75. GE Healthcare Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 76. Eckert & Ziegler Strahlen Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 77. Curium Pharma Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 78. Cardinal Health Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 79. Bracco Imaging Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 80. Aurobindo Pharma Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 81. ANSTO Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Figure 82. Acrotech Biopharma. Revenue Growth Rate in Medical Nuclide Products Business (2021-2026)
Scope & coverage.
Types
- Radiopharmaceuticals
- Radioactive Sources
- Medical Diagnostic Nuclides
- Others
Applications
- Hematological Diseases
- Cardiovascular Diseases
- Bone and Joint Diseases
- Cancer
- Others
Companies covered
- China Isotope & Radiation
- Dongcheng Pharma
- Eli Lilly
- Junan Pharmaceutical
- Bayer
- Siemens
- Q BioMed
- Progenics Pharmaceuticals
- Polatom
- NTP Radioisotopes
- NRG
- Novartis International AG
- Nordion
- Mundipharma
- Monrol
- Lantheus Medical Imaging, Inc.
- Jubilant Life Sciences
- International Isotopes
- GE Healthcare
- Eckert & Ziegler Strahlen
- Curium Pharma
- Cardinal Health
- Bracco Imaging
- Aurobindo Pharma
- ANSTO
- Acrotech Biopharma.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medical Nuclide Products by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Radiopharmaceuticals
- 2.2.3 Radioactive Sources
- 2.2.4 Medical Diagnostic Nuclides
- 2.2.5 Others
- 2.3 Medical Nuclide Products by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hematological Diseases
- 2.3.3 Cardiovascular Diseases
- 2.3.4 Bone and Joint Diseases
- 2.3.5 Cancer
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Medical Nuclide Products Breakdown Data by Type
- 3.1 Global Medical Nuclide Products Historic Market Size by Type (2021-2026)
- 3.2 Global Medical Nuclide Products Forecasted Market Size by Type (2027-2032)
4 Medical Nuclide Products Breakdown Data by Application
- 4.1 Global Medical Nuclide Products Historic Market Size by Application (2021-2026)
- 4.2 Global Medical Nuclide Products Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Medical Nuclide Products Market Perspective (2021-2032)
- 5.2 Global Medical Nuclide Products Growth Trends by Region
- 5.2.1 Global Medical Nuclide Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Medical Nuclide Products Historic Market Size by Region (2021-2026)
- 5.2.3 Medical Nuclide Products Forecasted Market Size by Region (2027-2032)
- 5.3 Medical Nuclide Products Market Dynamics
- 5.3.1 Medical Nuclide Products Industry Trends
- 5.3.2 Medical Nuclide Products Market Drivers
- 5.3.3 Medical Nuclide Products Market Challenges
- 5.3.4 Medical Nuclide Products Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Medical Nuclide Products Players by Revenue
- 6.1.1 Global Top Medical Nuclide Products Players by Revenue (2021-2026)
- 6.1.2 Global Medical Nuclide Products Revenue Market Share by Players (2021-2026)
- 6.2 Global Medical Nuclide Products Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Medical Nuclide Products Head Office and Area Served
- 6.4 Global Medical Nuclide Products Players, Product Type & Application
- 6.5 Global Medical Nuclide Products Manufacturers Established Date
- 6.6 Global Medical Nuclide Products Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Medical Nuclide Products Market Size (2021-2032)
- 7.2 North America Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Medical Nuclide Products Market Size by Country (2021-2026)
- 7.4 North America Medical Nuclide Products Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Medical Nuclide Products Market Size (2021-2032)
- 8.2 Europe Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Medical Nuclide Products Market Size by Country (2021-2026)
- 8.4 Europe Medical Nuclide Products Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Nuclide Products Market Size (2021-2032)
- 9.2 Asia-Pacific Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Medical Nuclide Products Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Medical Nuclide Products Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Medical Nuclide Products Market Size (2021-2032)
- 10.2 South America Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Medical Nuclide Products Market Size by Country (2021-2026)
- 10.4 South America Medical Nuclide Products Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Nuclide Products Market Size (2021-2032)
- 11.2 Middle East & Africa Medical Nuclide Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Medical Nuclide Products Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Medical Nuclide Products Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 China Isotope & Radiation
- 12.1.1 China Isotope & Radiation Company Information
- 12.1.2 China Isotope & Radiation Business Overview
- 12.1.3 China Isotope & Radiation Revenue in Medical Nuclide Products Business (2021-2026)
- 12.1.4 China Isotope & Radiation Medical Nuclide Products Product Portfolio
- 12.1.5 China Isotope & Radiation Recent Developments
- 12.2 Dongcheng Pharma
- 12.2.1 Dongcheng Pharma Company Information
- 12.2.2 Dongcheng Pharma Business Overview
- 12.2.3 Dongcheng Pharma Revenue in Medical Nuclide Products Business (2021-2026)
- 12.2.4 Dongcheng Pharma Medical Nuclide Products Product Portfolio
- 12.2.5 Dongcheng Pharma Recent Developments
- 12.3 Eli Lilly
- 12.3.1 Eli Lilly Company Information
- 12.3.2 Eli Lilly Business Overview
- 12.3.3 Eli Lilly Revenue in Medical Nuclide Products Business (2021-2026)
- 12.3.4 Eli Lilly Medical Nuclide Products Product Portfolio
- 12.3.5 Eli Lilly Recent Developments
- 12.4 Junan Pharmaceutical
- 12.4.1 Junan Pharmaceutical Company Information
- 12.4.2 Junan Pharmaceutical Business Overview
- 12.4.3 Junan Pharmaceutical Revenue in Medical Nuclide Products Business (2021-2026)
- 12.4.4 Junan Pharmaceutical Medical Nuclide Products Product Portfolio
- 12.4.5 Junan Pharmaceutical Recent Developments
- 12.5 Bayer
- 12.5.1 Bayer Company Information
- 12.5.2 Bayer Business Overview
- 12.5.3 Bayer Revenue in Medical Nuclide Products Business (2021-2026)
- 12.5.4 Bayer Medical Nuclide Products Product Portfolio
- 12.5.5 Bayer Recent Developments
- 12.6 Siemens
- 12.6.1 Siemens Company Information
- 12.6.2 Siemens Business Overview
- 12.6.3 Siemens Revenue in Medical Nuclide Products Business (2021-2026)
- 12.6.4 Siemens Medical Nuclide Products Product Portfolio
- 12.6.5 Siemens Recent Developments
- 12.7 Q BioMed
- 12.7.1 Q BioMed Company Information
- 12.7.2 Q BioMed Business Overview
- 12.7.3 Q BioMed Revenue in Medical Nuclide Products Business (2021-2026)
- 12.7.4 Q BioMed Medical Nuclide Products Product Portfolio
- 12.7.5 Q BioMed Recent Developments
- 12.8 Progenics Pharmaceuticals
- 12.8.1 Progenics Pharmaceuticals Company Information
- 12.8.2 Progenics Pharmaceuticals Business Overview
- 12.8.3 Progenics Pharmaceuticals Revenue in Medical Nuclide Products Business (2021-2026)
- 12.8.4 Progenics Pharmaceuticals Medical Nuclide Products Product Portfolio
- 12.8.5 Progenics Pharmaceuticals Recent Developments
- 12.9 Polatom
- 12.9.1 Polatom Company Information
- 12.9.2 Polatom Business Overview
- 12.9.3 Polatom Revenue in Medical Nuclide Products Business (2021-2026)
- 12.9.4 Polatom Medical Nuclide Products Product Portfolio
- 12.9.5 Polatom Recent Developments
- 12.10 NTP Radioisotopes
- 12.10.1 NTP Radioisotopes Company Information
- 12.10.2 NTP Radioisotopes Business Overview
- 12.10.3 NTP Radioisotopes Revenue in Medical Nuclide Products Business (2021-2026)
- 12.10.4 NTP Radioisotopes Medical Nuclide Products Product Portfolio
- 12.10.5 NTP Radioisotopes Recent Developments
- 12.11 NRG
- 12.11.1 NRG Company Information
- 12.11.2 NRG Business Overview
- 12.11.3 NRG Revenue in Medical Nuclide Products Business (2021-2026)
- 12.11.4 NRG Medical Nuclide Products Product Portfolio
- 12.11.5 NRG Recent Developments
- 12.12 Novartis International AG
- 12.12.1 Novartis International AG Company Information
- 12.12.2 Novartis International AG Business Overview
- 12.12.3 Novartis International AG Revenue in Medical Nuclide Products Business (2021-2026)
- 12.12.4 Novartis International AG Medical Nuclide Products Product Portfolio
- 12.12.5 Novartis International AG Recent Developments
- 12.13 Nordion
- 12.13.1 Nordion Company Information
- 12.13.2 Nordion Business Overview
- 12.13.3 Nordion Revenue in Medical Nuclide Products Business (2021-2026)
- 12.13.4 Nordion Medical Nuclide Products Product Portfolio
- 12.13.5 Nordion Recent Developments
- 12.14 Mundipharma
- 12.14.1 Mundipharma Company Information
- 12.14.2 Mundipharma Business Overview
- 12.14.3 Mundipharma Revenue in Medical Nuclide Products Business (2021-2026)
- 12.14.4 Mundipharma Medical Nuclide Products Product Portfolio
- 12.14.5 Mundipharma Recent Developments
- 12.15 Monrol
- 12.15.1 Monrol Company Information
- 12.15.2 Monrol Business Overview
- 12.15.3 Monrol Revenue in Medical Nuclide Products Business (2021-2026)
- 12.15.4 Monrol Medical Nuclide Products Product Portfolio
- 12.15.5 Monrol Recent Developments
- 12.16 Lantheus Medical Imaging, Inc.
- 12.16.1 Lantheus Medical Imaging, Inc. Company Information
- 12.16.2 Lantheus Medical Imaging, Inc. Business Overview
- 12.16.3 Lantheus Medical Imaging, Inc. Revenue in Medical Nuclide Products Business (2021-2026)
- 12.16.4 Lantheus Medical Imaging, Inc. Medical Nuclide Products Product Portfolio
- 12.16.5 Lantheus Medical Imaging, Inc. Recent Developments
- 12.17 Jubilant Life Sciences
- 12.17.1 Jubilant Life Sciences Company Information
- 12.17.2 Jubilant Life Sciences Business Overview
- 12.17.3 Jubilant Life Sciences Revenue in Medical Nuclide Products Business (2021-2026)
- 12.17.4 Jubilant Life Sciences Medical Nuclide Products Product Portfolio
- 12.17.5 Jubilant Life Sciences Recent Developments
- 12.18 International Isotopes
- 12.18.1 International Isotopes Company Information
- 12.18.2 International Isotopes Business Overview
- 12.18.3 International Isotopes Revenue in Medical Nuclide Products Business (2021-2026)
- 12.18.4 International Isotopes Medical Nuclide Products Product Portfolio
- 12.18.5 International Isotopes Recent Developments
- 12.19 GE Healthcare
- 12.19.1 GE Healthcare Company Information
- 12.19.2 GE Healthcare Business Overview
- 12.19.3 GE Healthcare Revenue in Medical Nuclide Products Business (2021-2026)
- 12.19.4 GE Healthcare Medical Nuclide Products Product Portfolio
- 12.19.5 GE Healthcare Recent Developments
- 12.20 Eckert & Ziegler Strahlen
- 12.20.1 Eckert & Ziegler Strahlen Company Information
- 12.20.2 Eckert & Ziegler Strahlen Business Overview
- 12.20.3 Eckert & Ziegler Strahlen Revenue in Medical Nuclide Products Business (2021-2026)
- 12.20.4 Eckert & Ziegler Strahlen Medical Nuclide Products Product Portfolio
- 12.20.5 Eckert & Ziegler Strahlen Recent Developments
- 12.21 Curium Pharma
- 12.21.1 Curium Pharma Company Information
- 12.21.2 Curium Pharma Business Overview
- 12.21.3 Curium Pharma Revenue in Medical Nuclide Products Business (2021-2026)
- 12.21.4 Curium Pharma Medical Nuclide Products Product Portfolio
- 12.21.5 Curium Pharma Recent Developments
- 12.22 Cardinal Health
- 12.22.1 Cardinal Health Company Information
- 12.22.2 Cardinal Health Business Overview
- 12.22.3 Cardinal Health Revenue in Medical Nuclide Products Business (2021-2026)
- 12.22.4 Cardinal Health Medical Nuclide Products Product Portfolio
- 12.22.5 Cardinal Health Recent Developments
- 12.23 Bracco Imaging
- 12.23.1 Bracco Imaging Company Information
- 12.23.2 Bracco Imaging Business Overview
- 12.23.3 Bracco Imaging Revenue in Medical Nuclide Products Business (2021-2026)
- 12.23.4 Bracco Imaging Medical Nuclide Products Product Portfolio
- 12.23.5 Bracco Imaging Recent Developments
- 12.24 Aurobindo Pharma
- 12.24.1 Aurobindo Pharma Company Information
- 12.24.2 Aurobindo Pharma Business Overview
- 12.24.3 Aurobindo Pharma Revenue in Medical Nuclide Products Business (2021-2026)
- 12.24.4 Aurobindo Pharma Medical Nuclide Products Product Portfolio
- 12.24.5 Aurobindo Pharma Recent Developments
- 12.25 ANSTO
- 12.25.1 ANSTO Company Information
- 12.25.2 ANSTO Business Overview
- 12.25.3 ANSTO Revenue in Medical Nuclide Products Business (2021-2026)
- 12.25.4 ANSTO Medical Nuclide Products Product Portfolio
- 12.25.5 ANSTO Recent Developments
- 12.26 Acrotech Biopharma.
- 12.26.1 Acrotech Biopharma. Company Information
- 12.26.2 Acrotech Biopharma. Business Overview
- 12.26.3 Acrotech Biopharma. Revenue in Medical Nuclide Products Business (2021-2026)
- 12.26.4 Acrotech Biopharma. Medical Nuclide Products Product Portfolio
- 12.26.5 Acrotech Biopharma. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst